Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001140361-26-034708
Filing Date
2026-08-27
Accepted
2026-08-27 16:28:26
Documents
1
Effectiveness Date
2026-08-27

Document Format Files

Seq Description Document Type Size
1 S-8 POS ef20081191_s8pos.htm S-8 POS 41891
  Complete submission text file 0001140361-26-034708.txt   43048
Mailing Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247
Business Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247 (310) 618-6994
Forte Biosciences, Inc. (Filer) CIK: 0001419041 (see all company filings)

EIN.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-265823 | Film No.: 261330954
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)